Symbols

BIOC(Delisted)

Biocept·NASDAQ

--(--)

BIOC fundamentals

BIOC Q2 undefined Earnings

Biocept (BIOC) released its earnings on Aug 10, 2017: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.

Revenue / YoY

EPS / YoY

Report date

Aug 10, 2017

Earnings

EPS

Revenue

Revenue & Expenses

BIOC has released its 2023 Q2 earnings report, with revenue of 589.00K, reflecting a YoY change of -89.88%, and net profit of -3.63M, showing a YoY change of 63.85%. The Sankey diagram below clearly presents BIOC's revenue sources and cost distribution.

Key Indicators

Biocept (BIOC) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Biocept (BIOC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Biocept (BIOC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Biocept (BIOC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown

Revenue Breakdown

Where does Biocept (BIOC) generate its revenue? Explore its key revenue streams and top earning regions.

By Business

Data source:

By Region

Data source:

Dividend

Track Biocept (BIOC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History

Payout Ratio

Dividend Yield

You can ask Aime

No Data